IMM2510, an anti-PD-L1/VEGF bispecific antibody fusion protein, in patients with advanced solid tumors: A phase I dose-escalation study

被引：0
|
作者：
Liu, Rujiao
Hu, Xichun
Song, Zhengbo
Zhang, Jian
Jin, Jianan
Gao, Shuiping
Sun, Yuping
Zhang, Yan
Gao, Shegan
Jia, Ruinuo
Jing, Deqiang
Xu, Yu
Wang, Zhenjiu
Lu, Qiying
Tian, Wenzhi
Cheng, Xiangdong
机构：
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Peoples R China
[3] Shandong Prov Inst Canc Prevent & Treatment, Jinan, Peoples R China
[4] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China
[5] ImmuneOnco Biopharmaceut Shanghai Inc, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14506
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Safety, antitumor activity, and pharmacokinetics of dostarlimab, an anti-PD-1, in patients with advanced solid tumors: a dose-escalation phase 1 trial
    Patnaik, Amita
    Weiss, Glen J.
    Rasco, Drew W.
    Blaydorn, Lisa
    Mirabella, Amy
    Beeram, Murali
    Guo, Wei
    Lu, Sharon
    Danaee, Hadi
    McEachern, Kristen
    Im, Ellie
    Sachdev, Jasgit C.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) : 93 - 103
  • [42] A phase 1 dose-escalation study of veliparib with bimonthly FOLFIRI in patients with advanced solid tumors.
    Berlin, Jordan
    Ramanathan, Ramesh K.
    Strickler, John H.
    Subramaniam, Deeps Suresh
    Hurwitz, Herbert
    Kang, Yoon-Koo
    Kim, Tae-You
    Shepherd, Stacie Peacock
    Xiong, Hao
    Hetman, Robert
    Nickner, Caroline
    Dudley, Matthew W.
    Giranda, Vincent L.
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [43] A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
    Becerra, Carlos R.
    Conkling, Paul
    Vogelzang, Nicholas
    Wu, Hilary
    Hong, Shengyan
    Narwal, Rajesh
    Liang, Meina
    Tavakkoli, Fatemeh
    Pandya, Naimish
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 917 - 925
  • [44] A phase I dose-escalation study of MEDI-575, a PDGFRα monoclonal antibody, in adults with advanced solid tumors
    Carlos R. Becerra
    Paul Conkling
    Nicholas Vogelzang
    Hilary Wu
    Shengyan Hong
    Rajesh Narwal
    Meina Liang
    Fatemeh Tavakkoli
    Naimish Pandya
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 917 - 925
  • [45] Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study
    An, Jusheng
    Tang, Jie
    Li, Benjamin X.
    Xiong, Huihua
    Qiu, Hui
    Luo, Lin
    Wang, Li
    Wang, Danbo
    Zhou, Qi
    Xu, Qin
    Song, Honglin
    Zhang, Yunyan
    Zhang, Hongping
    Li, Yujie
    Yu, Xiaohui
    Zhang, Jing
    Ng, Rachel
    Zhao, Wayne
    Wong, Michael
    Dai, Xiangrong
    Li, Guiling
    Wu, Lingying
    CLINICAL CANCER RESEARCH, 2022, 28 (23) : 5098 - 5106
  • [46] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [47] A Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of Pictilisib in Combination with Erlotinib in Patients with Advanced Solid Tumors
    Leong, Stephen
    Moss, Rebecca A.
    Bowles, Daniel W.
    Ware, Joseph A.
    Zhou, Jing
    Spoerke, Jill M.
    Lackner, Mark R.
    Shankar, Geetha
    Schutzman, Jennifer L.
    van der Noll, Ruud
    Voest, Emile E.
    Schellens, Jan H. M.
    ONCOLOGIST, 2017, 22 (12): : 1491 - 1499
  • [48] Phase I dose-escalation study of ON 01910. Na in combination with oxaliplatin in patients with advanced solid tumors
    Chaudhary, I.
    Rajdev, L.
    Swami, U.
    Wilhelm, F.
    Cohen, B.
    Haigentz, M.
    Kaubisch, A.
    Goel, S.
    Mani, S.
    Ghalib, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
    Sunil Sharma
    Joachim Beck
    Monica Mita
    Sofia Paul
    Margaret M. Woo
    Margaret Squier
    Brian Gadbaw
    H. Miles Prince
    Investigational New Drugs, 2013, 31 : 974 - 985
  • [50] A phase I dose-escalation and PK study of continuous oral rucaparib in patients with advanced solid tumors.
    Kristeleit, Rebecca Sophie
    Shapiro, Geoffrey
    LoRusso, Patricia
    Infante, Jeffrey R.
    Flynn, Michael
    Patel, Manish R.
    Tolaney, Sara M.
    Hilton, John Frederick
    Calvert, Alan Hilary
    Giordano, Heidi
    Isaacson, Jeffrey D.
    Borrow, Jennifer
    Allen, Andrew R.
    Jaw-Tsai, Sarah S.
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345